Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Teva Pharmaceutical to Replace CEO Kare Schultz

Teva Pharmaceutical to Replace CEO Kare Schultz

-Wall Street Journal

byCharles Gross

November 3, 2022

1 minute read

-Wall Street Journal

News

Genpact And Walmart Extend Partnership In North America

By Happy Mohamed

June 27, 8:08 AM

Contract extension builds on collaborative relationship to layer digital technology into finance operations NEW YORK, June 27, 2023 /PRNewswire/ -- Genpact (NYSE:G), a global professional services

News

Rio Tinto Partners With Aymium To Trial Renewable Biocarbon Product

By Benzinga Newsdesk

November 21, 11:02 AM

Rio Tinto and Aymium have partnered to develop and trial a renewable biocarbon product for use as an alternative resource to reduce emissions in large scale industrial processes.The product has been successfully trialled

RIO

JP Morgan Maintains Overweight on Visa, Raises Price Target to $265

By Benzinga Newsdesk

January 27, 9:43 AM

JP Morgan analyst Tien-Tsin Huang maintains Visa (NYSE:V) with a Overweight and raises the price target from $243 to $265.

M&A
News

Neogen Shareholders Approve All Proposals Required For Combination With 3M’s Food Safety Business

By Benzinga Newsdesk

August 17, 1:31 PM

Neogen Corporation ("Neogen") (NASDAQ:NEOG) announced that, at the special meeting of Neogen shareholders held today, Neogen shareholders voted to approve all proposals required in connection with the

MMM

Teva Pharmaceutical to Replace CEO Kare Schultz

Related Posts

Genpact And Walmart Extend Partnership In North America

Rio Tinto Partners With Aymium To Trial Renewable Biocarbon Product

JP Morgan Maintains Overweight on Visa, Raises Price Target to $265

Neogen Shareholders Approve All Proposals Required For Combination With 3M’s Food Safety Business